Operating Grant: Optimizing the VSV Vector towards an HIV Vaccine
Backgrounder
| Researcher | Institution | Project Title | Amount |
|---|---|---|---|
| Dr. Gary Kobinger | Laval University | Development of a safe, effective and clinically acceptable VSV-based HIV vaccine | $3,997,503 |
Page details
- Date modified: